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Abstract 
Objective: Pelvic organ prolapse (POP) is prevalent and can impact women’s physical and 
psychosocial health. To develop interventions that support this population, an understanding of 
the state of research on psychosocial factors related to POP is essential. We conducted a scoping 
study focused on the psychosocial experience of women with POP. The purpose of this review 
was to (1) inventory and describe the current state of knowledge of the psychosocial experience 
of women with POP, (2) identify gaps in knowledge, and (3) to identify targets for future 
research. Method: Electronic databases PsycINFO, PubMed, Embase, and Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) were searched through November 1, 2017. 
Results: Of 524 titles reviewed, 103 articles met all inclusion criteria. Articles were grouped by 
the disease period (i.e., pre-diagnosis, diagnosis/pre-intervention, intervention, follow-up, and 
mixed), and psychosocial factors. Most articles (n = 73) focused on women undergoing 
intervention. Articles focusing on the pre-intervention period was the next largest category (n = 
14). Follow-up after intervention (n = 8) and samples of mixed disease periods (n = 7) were less 
common. One article focused on women before diagnosis. Articles focused on quality of life 
(QOL; n = 79), sexual function (n = 51), satisfaction (n = 16), body image (n = 13), 
psychological distress (n = 4), and knowledge (n = 3). Conclusion: Research on the psychosocial 
experience of POP has largely focused on changes in QOL and sexual function. Future research 
should target: emotional experience of women with POP; relationships among QOL, 
psychological distress, body image, and sexual function; and psychosocial factors related to 
treatment outcomes.  
Keywords: Pelvic organ prolapse, quality of life, psychosocial, distress, sexual function  
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Introduction 
 Pelvic organ prolapse (POP) is symptomatic in 2.9% of US women [1, 2] and is 
surgically corrected in 12.6% of cases [3, 4]. POP occurs when pelvic muscles and tissues 
weaken or fail, resulting in the descent of pelvic organs (i.e., bladder, uterus, and small and large 
bowel), sometimes to the point that the vagina and uterus are visible outside of the body [4-6]. 
The development of POP is multifactorial and is most consistently related to vaginal parity, 
higher body mass index (BMI), and increasing age [4, 6]. Advanced POP is commonly defined 
as the leading edge of prolapse greater than 1 cm beyond hymen, while minimal POP reflects the 
leading edge at or above 1 cm beyond the hymen [4, 7]. With more advanced anatomical POP, 
the descending pelvic organs can displace the urethra and/or rectum leading to difficulty with 
urinary and/or fecal elimination or incontinence [4, 8]. POP can limit or impair physical 
functioning and sexual functioning, two important components of quality of life (QOL) [4, 9, 
10]. 
 It is unclear how much is known about women’s psychosocial experience in relation to 
POP. For the purpose of this review, psychosocial experience is defined as factors related to 
psychological and social function and well-being. These factors include psychological distress 
(i.e., depressive symptoms, anxiety, and stress), self-perceived body image, regret and 
satisfaction related to POP treatment, and sexual function. For the purpose of this review, QOL is 
also included in the umbrella term psychosocial experience. QOL is a broad construct, 
incorporating many factors related to the psychosocial experience of women with POP. QOL 
encompasses both general health-related QOL (i.e., physical, mental, emotional, and social 
functioning) [11] and POP-specific QOL (i.e., the presence, intensity, and interference of POP-
related symptoms) [12, 13].  
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To the best of our knowledge, there is no published review focused on the psychosocial 
experience related to the diagnosis and treatment of POP. In other illness states, the psychosocial 
experience of disease can profoundly affect treatment outcomes [14]. For example, pre-operative 
depression predicts morbidity following coronary bypass surgery[15], pre-operative 
psychological distress and catastrophizing predict pain following total knee arthroplasty[16], and 
psychological distress and dysfunction are risk factors for poor outcomes following back surgery 
[17]. The psychosocial experience may be particularly important in predicting pain and other 
outcomes in elective surgery [14]. Thus, it seems reasonable to explore women’s psychosocial 
experiences related to the diagnosis and treatment of POP.   
We conducted a scoping study focused on the psychosocial experience of women 
diagnosed with and/or treated for POP. Our aims were consistent with the widely accepted 
purpose of a scoping study. A scoping study aims to summarize the state of research on a topic 
that may have been previously neglected, or has not yet been reviewed, and to identify gaps in 
knowledge and targets for future research [18].  It differs from a meta-analysis or systematic 
review in that it aims to assess the scope of research on a particular subject without focusing on a 
specific research question [18]. A scoping study incorporates a wide range of study designs and 
addresses questions beyond intervention efficacy, as is done in a meta-analysis or systematic 
review, and therefore provides a more comprehensive summary of the totality of available 
literature on a topic.  
Materials and Methods 
To complete the scoping study, we followed Arksey and O’Malley’s [18, 19] framework 
and guidelines. Their 5 stages for investigating a review topic are: (1) identifying the research 
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problem, (2) identifying relevant studies, (3) study selection, (4) charting the data; and (5) 
collating, summarizing, and reporting the results.  
Identifying the research problem 
With this research, we aimed to answer the following questions: (1) what is the current 
state of knowledge of the psychosocial experience of women with POP; (2) where are there gaps 
in knowledge; and (3) what future research is needed? We did not comment on the quality of 
research included and this was consistent with the primary purpose and philosophy of scoping 
studies, which is to map out the current literature on a topic. Adopting a less conservative 
approach to study inclusion for a scoping study ensures that studies of varying design and 
methodology are included.  
Identifying relevant studies 
The electronic databases PsycINFO, PubMed, Embase, and the Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) were searched through November 1, 2017. No 
restrictions on publication date were applied. Search terms were based on the medical definition 
of POP. Psychosocial search terms were adapted from a review paper examining the 
psychosocial experience of women with endometriosis, which shares many salient features with 
POP (i.e., (1) the disease affects the sexual organs in women, (2) it is a painful and hidden 
condition, (3) diagnosis is difficult without physical examination, (4) treatment often requires 
surgery, (5) it impacts sexual function, and (6) it is associated with changes in body image, 
psychological well-being, and QOL [20].  
The following search terms were used for each database: (pelvic organ prolapse OR 
pelvic prolapse OR organ prolapse OR uterine prolapse OR apical prolapse OR cystocele OR 
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rectocele OR sigmoidocele OR enterocele) AND (coping OR distress OR psychological distress 
OR emotion OR psychosocial OR psychosocial well-being OR psychological well-being OR 
subjective well-being OR well-being OR affect OR identity OR sexual function OR stigma OR 
expectations OR quality of life OR QOL OR anxiety OR depression OR depressive OR mental 
health OR body image OR self-image OR personality OR social support OR social well-being 
OR health literacy). In this study, sexual function refers to several domains of the sexual 
experience (i.e., arousal, orgasm, satisfaction, lubrication, dyspareunia, and perceptions of 
partner satisfaction and experience). 
Study Selection 
 Articles were screened based on the following inclusion and exclusion criteria. Studies 
needed to be: (1) published in a peer-reviewed journal, (2) available in English, and (3) focused 
on the following topics: (a) psychosocial variables in women diagnosed with POP, (b) health-
related or symptom-related QOL associated with POP or intervention for POP, (c) the 
psychosocial experience before and/or after intervention for POP, (d) psychosocial outcomes 
associated with different surgical or non-surgical interventions, or (d) patient-reported symptoms 
or functional outcome associated with POP or intervention for POP. Because we sought to be 
inclusive of all relevant studies, we did not exclude studies by methodology. Quantitative, 
qualitative, pilot, and exploratory studies were all considered for inclusion. Studies were 
excluded if: (1) they focused solely on validating survey measures or (2) their primary purpose 
was on the comparative efficacy of medical interventions without a focus on the psychosocial 
experience.  
Charting the data 
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For each included article, the following information was extracted: (1) author and year of 
publication; (2) research aim; (3) reported psychosocial variables (4) standardized measures of 
psychosocial variables, if reported; (5) number of participants included in the analyses; (6) mean 
age and standard deviation of the sample, if reported; (7) authors’ conclusions; and (8) period of 
disease the sample was in. The period of disease was categorized as (1) pre-diagnosis, (2) 
diagnosis/pre-intervention, (3) intervention, (4) follow-up, and (5) mixed. For articles that 
focused on patients in the intervention and follow-up stages, the number of time points and 
follow-up schedule was also noted.    
Results 
A total of 524 unique articles were reviewed. One hundred and three articles met all 
inclusion criteria and are summarized in this review (Figure 1). The results are organized 
according to disease period and supplemented by tables. Table 1 summarizes measurement tools 
used to assess the psychosocial experience. Table 2 provides an overall summary of the studies 
and findings. Table 3 describes the psychosocial experience by disease. 
 The articles were categorized into the following disease periods: (1) pre-diagnosis (n = 1, 
1.0%); (2) diagnosis/pre-intervention (n = 14, 13.6%); (3) intervention (n = 73, 70.9%); (4) 
follow-up (n = 8, 7.8%); and (5) mixed (n = 7, 6.8%). Eight categories of psychosocial variables 
were found in the included studies: (1) POP-specific QOL (n = 77, 74.8%); (2) sexual function (n 
= 51, 49.5%); (3) satisfaction (n = 16, 15.5%); (4) general health related QOL (n = 12, 11.7%); 
(5) body image (n = 13, 12.6%); (6) knowledge of POP (n = 6, 5.8%); and (7) psychological 
distress (n = 4, 3.9%). Not all variables related to psychosocial experience were reported in each 
disease period (Table 3). 
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Pre-diagnosis 
 One study focused on prevalence of POP-related symptoms, awareness of several pelvic 
floor disorders in family members, and understanding of factors that contribute to these disorders 
in young and adolescent women not diagnosed with POP [21]. Few women reported symptoms, 
were aware of POP in family members, or knew about factors that contribute to POP [21].  
Diagnosis/pre-treatment 
Quality of life 
 There was no difference in overall POP-specific QOL by prolapse type [22]. Women 
with more severe anatomical POP reported more POP-related symptoms (i.e., worse POP-
specific QOL) [12]. Patient treatment goals also differed by severity of anatomical POP, though 
the goals reported centered around resolution of symptoms and improvement of POP-specific 
QOL, regardless of POP stage [23]. Women with POP had worse general health related QOL in 
the physical domain and worse POP-specific QOL than healthy women, but there was no 
difference between groups in the mental domain of general health related QOL [24]. Women 
awaiting surgery for POP reported similar deficits in general health related QOL as women 
awaiting hip or knee replacement [25]. The wait time for POP surgery was more than twice that 
for hip or knee replacement [25]. Pelvic floor muscle function was not associated with POP-
specific QOL [26]. 
Sexual function 
 Sexual function was not related to minimal anatomical POP [27]. However, women with 
more severe anatomical POP reported worse sexual function than healthy women [28]. There 
was no difference in sexual function by prolapse type [22]. 
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Knowledge of POP 
 Women had poor understanding of POP and its treatment [29, 30], even with high health 
literacy [29]. Women reported poor disease understanding and knowledge of POP as barriers to 
seeking treatment [31, 32]. Women reported that they are not being educated about POP, risk 
factors, or treatment options by their health care providers [31], and that feelings of guilt and 
blaming oneself also kept them from seeking treatment [32]. 
Body image  
 Women with POP reported worse self-perceived body image [24] and having more 
severe POP-related symptoms was associated with worse body image [33]. Poorer body image 
correlated with poorer scores on the mental domain of QOL, regardless of presence of POP [24].  
Psychological distress 
 Women who reported more depressive symptoms reported more severe POP-related 
symptoms and worse general health related QOL, regardless of the severity of anatomical POP 
[34].  
Intervention 
 Studies in the intervention period focused on changes in psychosocial experience before 
and after intervention. 
POP-specific quality of life  
All studies found that POP-specific QOL improved after reconstructive surgery [35-65]. 
There was no difference in improvement in POP-specific QOL following surgery by age group 
[66]. Women who had undergone obliterative surgery also reported improved POP-specific QOL 
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[46, 67-70]. Use of a pessary was also associated with improved POP-specific QOL [45, 71-73]. 
Biofeedback paired with pelvic floor muscle training (PFMT) improved POP-specific QOL [74]. 
Follow up periods for outcome measurement varied widely, from six months to five years.  
One study examined pre-intervention scores on two measures of POP-specific QOL as 
predictors of improvement in POP-specific QOL following intervention [60]. Women with worse 
POP-specific QOL at baseline were more likely to report improvement at follow-up [60]. 
General health related quality of life  
 General health related QOL also improved following reconstructive surgery [61, 66, 75-
79]. Women who underwent obliterative surgery also reported improvement in general health 
related QOL [80]. Pessary use was also associated with improved general health related QOL 
[78]. Follow-up ranged from three to 18 months.  
Satisfaction 
 Most women reported being satisfied after reconstructive surgery [43, 46, 47, 49, 81-83]. 
Satisfaction following reconstructive surgery was associated with patient preparedness for 
surgery [84], patient treatment-related goal achievement [85], age at surgery and follow-up [83], 
menopausal status [83], BMI [83], and presence of POP symptoms [83]. Women who underwent 
obliterative surgery also reported being satisfied [46, 67, 70, 80].  
Sexual function 
 Outcomes for sexual function following reconstructive surgery varied. Most studies 
reported improvement in sexual function following reconstructive surgery [35, 41, 42, 54, 57, 58, 
61, 63, 65, 79, 86-92]. Sexual function improved similarly with abdominal and transvaginal 
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surgery [65]. Women who underwent a hysterectomy [81, 91, 93] or a trachelectomy [82] 
concurrent with surgical repair of POP also reported improvement in sexual function. Male 
partner sexual function improved following surgery in one study [89], but no change was 
reported in another [86]. Follow-up ranged from three months to three years following surgery. 
Several studies reported no change in sexual function following reconstructive surgery 
[36, 37, 39, 66, 86, 94-99]. Other studies reported declines in sexual function following 
reconstructive surgery [51, 62, 100]. Postmenopausal women reported worse sexual function 
after surgery than premenopausal women [101]. Follow-up ranged from six months to three 
years after surgery. 
The impact of non-surgical interventions on sexual function also varied. There was no 
difference in sexual function between women who had undergone PFMT and those who did not, 
however, more women in the PFMT group reported improved sexual function [102]. Two studies 
examining pessary use reported no change in sexual function [103, 104], while another study 
reported that sexual function improved with pessary use [78]. 
Several factors were identified that may influence sexual function outcomes. Follow-up 
period may impact outcomes, as sexual function declined immediately following surgery but 
improved over time, in one study [105]. Site of reconstructive surgery may also impact sexual 
function outcomes, as one study found that women who had anterior or posterior repair alone, 
reported improvement in sexual function, while women who had both anterior and posterior 
repair reported no change [106]. In one study, reduced coital incontinence and better overall 
health predicted improvement in sexual function following surgery, while psychological distress 
predicted decline [100]. However, another study found that sexual function was driven by 
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behavioral-emotive (i.e., desire) and partner related (i.e., ability to maintain an erection) domains 
rather than factors in the physical domain (i.e., pain) [107]. 
Body image 
 Reconstructive surgery [45, 61, 78], use of a pessary [45, 73], and obliterative surgery 
[70, 80] were associated with improvement in self-perceived body image. 
Psychological distress 
 Women with POP reported more depressive symptoms than women without POP, and 
depressive symptoms improved six months after surgery [108]. Rural Nepalese women who had 
worse general health related QOL, also had worse depression scores, and both depression and 
general health related QOL improved three months following surgery [77]. 
Follow-up 
 Follow-up articles examined psychosocial factors after intervention but did not compare 
these factors to baseline levels.  
Women with POP were compared to women without POP after having previously 
undergone surgical removal of the cervix; women without POP reported greater satisfaction, 
better general health related QOL, and better sexual function [109].  
Women who had previously undergone transvaginal reconstructive surgery reported good 
POP-specific QOL [110]. Women who had previously undergone obliterative surgery reported 
deficits in sexual function [111] and body image [111, 112]. However, most reported low regret, 
improvement in POP-specific QOL, and were satisfied [111-113]. Women who reported better 
POP-specific QOL after surgery were more likely to be satisfied [114]. 
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 Women with recurrent POP reported similar barriers to seeking treatment as treatment 
naïve women, including beliefs about aging, availability of treatment, trivializing the importance 
of symptoms, and the high workload of doctors [115]. 
Mixed  
 This category includes studies that focused on women in various disease periods.   
Women who reported more POP-related symptoms, had worse general health related 
QOL [116]. Women in the 6th and 7th decade of life were more bothered by POP-related 
symptoms than women who were younger or older with the same stage of prolapse [117].  
 Women with POP reported worse sexual function in both behavioral-emotive and 
physical domains, compared to women without POP [118]. Deficits in sexual function were 
associated with worse body image and more severe POP-related symptoms, regardless of POP 
stage [119]. Women with POP that had not been surgically corrected reported worse genital body 
image than women without POP, but women with surgically corrected POP did not differ from 
either group [120]. Worse genital body image was uniquely associated with worse sexual 
function in all groups, when general body image was controlled for [120]. 
Women reported shame, anxiety, frustration, hopelessness, and acceptance related to POP 
[9]. Deficits in self-image, social activity (i.e., being more housebound), hygiene, and discomfort 
were reported [9]. 
 Approximately one-third of women with symptomatic prolapse reported depressive 
symptoms [121]. Depressive symptoms were related to urinary tract symptoms and bowel 
dysfunction but not prolapse stage [121]. 
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Discussion 
In this scoping study, we mapped out literature on the psychosocial experience of women 
diagnosed with and/or treated for pelvic organ prolapse (POP). The first major conclusion of this 
review is that there is considerable variability in what outcomes have been measured and the 
length of follow-up after intervention. QOL and sexual function were the most consistently 
reported variables, whereas variables such as psychological distress and knowledge of POP were 
relatively neglected. There was a wide range in the length of follow-up reported, from a few 
months to several years. One study found that sexual function declined in the first three months 
after surgery, and then improved over time, such that it had reached statistically significant 
improvement at two years after surgery [105]. Researchers and clinicians should work together 
to develop a toolkit of suggested measures and assessment timeframes. 
The second major conclusion of this review is that because the impact of psychosocial 
factors on treatment outcomes, such as recovery, was unexplored, more research is needed to 
examine psychosocial predictors of treatment outcomes in POP. Psychological distress predicts 
outcomes in other surgeries [14-17], and the impact of psychological distress on outcomes in 
POP treatment should be examined. For example, in healthy women, psychological distress is 
known to impact sexual function [122] but the relationship between psychological distress and 
sexual function outcomes has not been explored in women with POP. Also, women with worse 
depressive symptoms reported worse POP-related symptoms, regardless of the severity of 
anatomical POP [34]. How psychological well-being impacts the subjective experience of POP 
has not been adequately explored. Further, factors, such as expectancy [123], that have been 
shown to predict treatment outcomes in other diseases, were not explored in women with POP. 
In a sample with mixed pelvic floor disorders, trait optimism predicted subjective report of 
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pelvic floor symptoms, such that those with greater trait positive expectancy reported less 
symptoms and less distress related to symptoms[124]. The ability of positive expectancies to 
predict treatment outcomes in POP should be explored.  
The third major conclusion is that significant gaps exist in the current literature that 
justify future research. Such gaps preclude our understanding of the POP psychosocial 
experience and interfere with the ability to provide evidence-based care to improve psychosocial 
outcomes. The five main areas where future research is needed are described below. 
First, future research should determine the relationship between POP and psychological 
distress, body image, and sexual function. Women reported concerning deficits in body image, 
sexual function, and psychological well-being. Future research should clarify how POP impacts 
these factors and vice versa. As studies found that body image and depression were associated 
with severity of self-rated symptoms (i.e., worse POP-specific QOL), regardless of severity of 
anatomical POP [34, 119], it is important to determine how deficits in psychological well-being 
impact the subjective experience of POP.  
Second, future research should clarify the impact of POP treatment on sexual function. 
Sexual function outcomes varied widely after both surgical and non-surgical treatment for POP. 
Studies reported no change, decline, or improvement following treatment. As POP is consistently 
associated with deficits in sexual function, and improved sexual function is a commonly 
measured outcome variable and indicator of treatment success, it is important to establish factors 
that predict improvement. Factors that were identified as being associated with sexual function 
outcomes should be expanded upon and confirmed. These factors included the length of follow-
up, coital incontinence, general health status, and type of surgery.  
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Third, future research should determine factors that impact or predict treatment 
outcomes. Factors such as psychological distress [125], expectancy [122], and goal-related traits 
(i.e., self-efficacy and optimism) [126, 127] have been established as predictors of surgical and 
treatment outcomes (i.e., recovery) in other illnesses. These factors should be examined in 
women undergoing treatment for POP. Establishing the impact of pre-intervention psychological 
factors on surgical outcomes may help physicians to optimize treatments and recovery for 
patients with POP. 
Fourth, future research should aim to improve knowledge of POP in health care 
consumers. Knowledge related to POP was poor [29, 30]. Poor knowledge of POP and 
understanding of treatment was reported as a barrier to treatment in several studies [31, 32]. Poor 
understanding of POP and its treatment was reported even by women who had previously 
undergone treatment for POP [115]. Research focusing on improving knowledge, recognizing 
and reducing barriers to treatment, and improving treatment seeking in women with symptomatic 
POP is warranted.   
Fifth and finally, future research should establish the influence of length of follow-up on 
treatment outcomes. The follow-up periods for treatment outcomes varied widely across studies, 
with some studies reporting outcomes several months after surgery and other reporting outcomes 
after several years. The impact of length of follow-up on outcomes, such as recovery, should be 
established. Further, identification of factors that predict the trajectory of outcomes over time 
(i.e., differential recovery trajectories) may help physicians to counsel patients about surgery and 
expected outcomes over time.  
 Our scoping study findings should be interpreted in light of some limitations. First, as this 
was a scoping study, the sections describing research related to POP and sexual function were 
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intentionally broad out of necessity, to give our study group the latitude to be inclusive in other 
subject areas. A separate review of the psychosocial factors facing women with sexual 
dysfunction and POP might also be beneficial for the readership. Second, we did not assess the 
quality of included research, which was consistent with how scoping studies are typically 
conducted. Additional implications for future research may be identified once the quality of the 
research is assessed. For example, areas of existing but methodologically poor research may 
suggest a need for additional research, though many areas in need of research have already been 
identified in this review. Third, relevant research may have unintentionally been omitted from 
this review based on inclusion/exclusion criteria, search terms, and/or databases searched. Hand 
searching of relevant journals was not performed, such that studies that were not available in 
online databases were not included. This may have resulted in an omission of relevant research. 
Additionally, some relevant research may have been omitted due to the specificity of the search 
terms used, as our goal was to be specific to POP and not all pelvic floor disorders. We chose to 
use specific search terms in order for our methods to be replicable and with the expectation that 
missing results would be random and the review comprehensive.  Fourth, a single reviewer 
coded the articles in this review. Therefore, the included articles may be subject to selection bias 
as inclusion and exclusion decisions reflect the opinion of one reviewer. However, this study is 
strengthened by the significant involvement and authorship of M.H.H.; M.H.H. is a fellowship 
trained surgeon in the field of female pelvic medicine and reconstructive surgery, who has a PhD 
in epidemiology and clinical research and has provided expert consultation from development to 
completion of this project. 
Conclusion 
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 Research focusing on the psychosocial experience of women with POP is relatively new, 
with most studies focusing on sexual function and QOL in these women. Future research should 
focus on factors that predict treatment outcomes, the relationship between POP and 
psychological distress, knowledge of POP and barriers to treatment, and how the length of the 
follow-up impacts measured outcomes. Developing a deeper understanding of the psychosocial 
experience of having this disorder may help clinicians to improve care for their patients and may 
help consumers better advocate for themselves when seeking healthcare. 
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